Clinuvel PharmaceuticalsCUV 
$10.13-1.19%24h
-1.19%24h
Global rank11332
Market cap$500.75M
Change 7d-
YTD Performance-6.43%
SP500 benchmarkUnderperform
P/E17.15
P/S9.45
Revenue$52.99M
Earnings$20.71M
Dividend yield-
Main Sector
Healthcare
Category
Clinuvel Pharmaceuticals (CUV) Cash on Hand
CUV Cash on Hand in 2022: $106.09M
According to Clinuvel Pharmaceuticals latest financial reports the cash on hand of CUV is $106.09M, an increase of 29.05% to 2022. At the end of 2022 company had $82.21M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
CUV Cash on Hand History from 2019 to 2023
-
Value:-
CUV Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $106.09M | 29.05% |
| 2022 | $82.21M | 46.94% |
| 2021 | $55.94M | 23.89% |
| 2020 | $45.16M | 22.99% |
| 2019 | $36.71M | - |
View the Top Cash on Hand Companies 
